Edward Cha

3.6k citations
42 papers · 2.4k · 2 hit papers · h-index 21

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cytokine Signaling Pathways and Interactions
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • interferon and immune responses

Papers in

    • Cancer Immunotherapy and Biomarkers 19
    • Colorectal Cancer Treatments and Studies 5
    • CAR-T cell therapy research 3
    • Immunotherapy and Immune Responses 10
    • Immune Cell Function and Interaction 4
    • T-cell and B-cell Immunology 3

Edward Cha

40 papers receiving 2.3k citations

Edward Cha's Hit Papers

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study 2025 · 47 citations
470+1+2Years since publication100200300

Peers

Edward Cha
Comparison fields: 5 of 80
  • Oncology 1.3k
  • Immunology 845
  • Hepatology 292
  • Cancer Research 189
  • Pulmonary and Respiratory Medicine 292
Replace Valerie Chew with:
Valerie Chew Singapore
Anupam M. Desai United States
Jingwei Sun China
Ligia Craciun Belgium
Catherine Sibille Belgium
Joanna Mangana Switzerland
Yoshitaro Shindo Japan
Maria Libera Ascierto United States
Gabriel Abril Rodriguez United States
Yingjie Bian United States
Edward Cha relative to Valerie Chew Singapore Valerie Chew's profile →
Citations per field
00.5×1.5×
Valerie Chew · 1×
Citations per year

Countries citing papers authored by Edward Cha

Since Specialization
Citations

This map shows the geographic impact of Edward Cha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Cha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Cha more than expected).

Fields of papers citing papers by Edward Cha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Cha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Cha. The network helps show where Edward Cha may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward Cha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Cha Line = papers co-authored together Edward Cha links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2023362
2 2014337
3 2000329
4 2020233
5 2019199
6 2019144
7 201757
8 200854
9 202349
10 201247
11
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
Hit paper breakdown →
202547
12 201143
13 201542
14 201236
15 202035
16 201631
17 201530
18 202330
19 202129
20 201528

About Edward Cha

Edward Cha is a scholar working on Oncology, Immunology, Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 42 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Immunotherapy and Immune Responses (10 papers), Colorectal Cancer Treatments and Studies (5 papers), Immune Cell Function and Interaction (4 papers), Prostate Cancer Treatment and Research (4 papers), CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (845 citations), Hepatology (292 citations), Cancer Research (189 citations) and Pulmonary and Respiratory Medicine (292 citations). Edward Cha has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Lawrence H. Fong, Christopher Y. Park, Christian Schindler, Yafei Hou, Malek Faham, Antoni Ribas, Mark Klinger, Craig A. Cummings, ADIL I. DAUD and Serena S. Kwek. Their work appears in journals such as Annals of Oncology, The Lancet Oncology, Journal for ImmunoTherapy of Cancer, OncoImmunology and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact